China's FDA Reform Will Encourage Life Science Innovation
The China Food and Drug Administration Office (CFDA) continues to reform the current review and approval system for drugs and devices, according to a circular entitled the Opinions Regarding Strengthening the...To view the full article, register now.
Already a subscriber? Click here to view full article